REVVITY, INC. (RVTY)
Laboratory Analytical Instruments · Laboratory Analytical Instruments · NYSE
$119.45
+5.01%
Investingg Score
41.7 / 100
Sell
Business overview
- Operating margin of 12.5%
- Free cash flow margin of 17.8%
These figures demonstrate that the company generates solid cash flows relative to its revenue, reflecting steady core business execution.
Financial health
- Balance sheet pillar score of 49
- Free cash flow yield of 3.8%
Together, these metrics indicate a moderate financial position with reasonable cash generation capabilities, though specific debt figures are unavailable.
- Gross Margin
- Data unavailable
- Operating Margin
- 12.5%
- Current Ratio
- 1.7x
- Debt / Equity
- 0.36
- Free Cash Flow (TTM)
- $0.5B
- Interest Coverage
- 4x
Valuation
- P/E ratio of 69.44
- Forward P/E ratio of 20.29
- EV/EBITDA of 36.84
- P/S ratio of 4.69
These valuation multiples suggest that current earnings are expensive on a trailing basis, though future earnings expectations show potential moderation.
- P/E (TTM)
- 69.4x
- Forward P/E
- 20.3x
- Price / Sales
- 4.7x
- EV / EBITDA
- 36.8x
- FCF Yield
- 3.8%
Key risks
- Earnings per share declined year-over-year by 5.9%, indicating potential margin or cost pressures.
- The trailing P/E ratio is elevated at 69.44, introducing valuation risk if forward growth expectations are not met.
- The overall Investingg Score is low at 41.7 with a Sell verdict, reflecting broader fundamental and structural concerns.
Market cap $13.4B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze RVTY with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.